Generally, aminocaproic acid has been fairly well tolerated, and there is literature to support its relative safety in patients with liver disease. Antifibrinol ...

In this paper, we will discuss coagulopathy, increased risk of thrombosis, and their management in decompensated liver cirrhosis.

Transfusion of fresh frozen plasma is the hallmark of treatment of significant coagulopathy in patients with liver disease and active bleeding.

Anticoagulation is essential in all patients with acute PVT and suspected intestinal ischemia and should immediately be started subcutaneously or parenterally.

24 сент. 2021 г. · This document presents the official recommendations of the American Gastroenterological Association Institute (AGA) on the management of ...

15 дек. 2022 г. · Optimal coagulation management in these complex patients should be based on the analysis of standard coagulation tests (SCTs) and viscoelastic ...

5 дек. 2015 г. · Standard treatment for acute variceal hemorrhage includes a combination of a vasoconstrictor and endoscopic therapy. Recent United Kingdom ... Abstract · Management of active bleeding · Conclusions

15 февр. 2021 г. · The current consensus is that in patients with cirrhosis, the hemostasis is shifted towards a procoagulant state.

16 июл. 2018 г. · This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.

12 апр. 2019 г. · Tranexamic acid is recommended at a dose of 1 g IV every 6 hours. These are rarely used prophylactically, but more commonly used as a rescue ...